Danaher Gross Profit 2010-2024 | DHR

Danaher annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Danaher gross profit for the quarter ending December 31, 2024 was $3.890B, a 2.94% increase year-over-year.
  • Danaher gross profit for the twelve months ending December 31, 2024 was $14.206B, a 1.23% increase year-over-year.
  • Danaher annual gross profit for 2024 was $14.206B, a 1.23% increase from 2023.
  • Danaher annual gross profit for 2023 was $14.034B, a 13.31% decline from 2022.
  • Danaher annual gross profit for 2022 was $16.188B, a 6.23% increase from 2021.
Danaher Annual Gross Profit
(Millions of US $)
2024 $14,206
2023 $14,034
2022 $16,188
2021 $15,239
2020 $12,475
2019 $9,984
2018 $9,505
2017 $8,571
2016 $9,335
2015 $7,771
2014 $6,850
2013 $9,342
2012 $9,414
2011 $8,177
2010 $6,405
2009 $5,070
Danaher Quarterly Gross Profit
(Millions of US $)
2024-12-31 $3,890
2024-09-30 $3,401
2024-06-30 $3,428
2024-03-31 $3,487
2023-12-31 $3,779
2023-09-30 $3,275
2023-06-30 $3,318
2023-03-31 $3,662
2022-12-31 $2,178
2022-09-30 $4,584
2022-06-30 $4,721
2022-03-31 $4,705
2021-12-31 $2,230
2021-09-30 $4,359
2021-06-30 $4,397
2021-03-31 $4,253
2020-12-31 $3,954
2020-09-30 $3,226
2020-06-30 $2,852
2020-03-31 $2,443
2019-12-31 $2,704
2019-09-30 $2,441
2019-06-30 $2,484
2019-03-31 $2,355
2018-12-31 $1,354
2018-09-30 $2,691
2018-06-30 $2,817
2018-03-31 $2,644
2017-12-31 $1,218
2017-09-30 $2,537
2017-06-30 $2,482
2017-03-31 $2,334
2016-12-31 $2,500
2016-09-30 $2,286
2016-06-30 $2,381
2016-03-31 $2,167
2015-12-31 $766
2015-09-30 $1,893
2015-06-30 $2,644
2015-03-31 $2,468
2014-12-31 $2,804
2014-09-30 $2,452
2014-06-30 $2,620
2014-03-31 $2,453
2013-12-31 $2,712
2013-09-30 $2,425
2013-06-30 $2,496
2013-03-31 $2,326
2012-12-31 $2,545
2012-09-30 $2,278
2012-06-30 $2,356
2012-03-31 $2,236
2011-12-31 $2,327
2011-09-30 $2,183
2011-06-30 $1,918
2011-03-31 $1,749
2010-12-31 $1,718
2010-09-30 $1,612
2010-06-30 $1,606
2010-03-31 $1,469
2009-12-31 $1,228
2009-09-30 $1,321
2009-06-30 $1,262
2009-03-31 $1,259
Sector Industry Market Cap Revenue
Medical Medical Services $150.197B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $90.566B 11.84
CVS Health (CVS) United States $82.065B 12.01
Cencora (COR) United States $47.211B 17.13
DiDi Global (DIDIY) China $23.282B 0.00
Natera (NTRA) United States $22.205B 0.00
ICON (ICLR) Ireland $16.651B 14.81
BioMerieux (BMXMF) France $14.074B 0.00
Doximity (DOCS) United States $14.002B 72.82
Revvity (RVTY) United States $13.962B 23.41
Viatris (VTRS) United States $13.201B 4.07
Solventum (SOLV) United States $12.870B 0.00
Avantor (AVTR) United States $11.909B 17.49
CochLear (CHEOY) Australia $11.330B 0.00
Medpace Holdings (MEDP) United States $10.506B 27.30
EUROFINS SCIENT (ERFSF) Luxembourg $9.794B 0.00
HealthEquity (HQY) United States $9.682B 48.57
Sonic Healthcare (SKHHY) Australia $8.686B 0.00
Charles River Laboratories (CRL) United States $8.297B 15.72
Amplifon S.p.A (AMFPF) Italy $6.224B 31.72
Bausch + Lomb (BLCO) Canada $5.601B 25.63
Organon (OGN) United States $4.041B 4.12
Sotera Health (SHC) United States $3.829B 20.49
BrightSpring Health Services (BTSG) United States $3.552B 75.56
Surgery Partners (SGRY) United States $3.263B 37.20
Concentras Parent (CON) United States $2.981B 0.00
GeneDx Holdings (WGS) United States $2.791B 338.60
Alignment Healthcare (ALHC) United States $2.755B 0.00
Teladoc Health (TDOC) United States $2.185B 0.00
Ardent Health Partners (ARDT) United States $2.118B 0.00
Progyny (PGNY) United States $2.033B 41.17
PACS (PACS) United States $2.010B 0.00
GoodRx Holdings (GDRX) United States $1.852B 48.60
Premier (PINC) United States $1.726B 11.05
Agilon Health (AGL) United States $1.492B 0.00
Pediatrix Medical (MD) United States $1.480B 12.40
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
CareDx (CDNA) United States $1.254B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 7.81
Establishment Labs Holdings (ESTA) $0.981B 0.00
Embecta (EMBC) United States $0.838B 5.74
Auna S.A (AUNA) Luxembourg $0.611B 0.00
DocGo (DCGO) United States $0.513B 19.35
SBC Medicals (SBC) United States $0.483B 0.00
Sonida Senior Living (SNDA) United States $0.480B 0.00
MultiPlan (MPLN) United States $0.477B 0.00
InnovAge Holding (INNV) United States $0.453B 0.00
Enhabit (EHAB) United States $0.424B 36.70
Nutex Health (NUTX) United States $0.335B 0.00
LifeMD (LFMD) United States $0.326B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.311B 0.00
QDM (QDMI) Hong Kong, SAR China $0.294B 7.71
Beauty Health (SKIN) United States $0.199B 0.00
Performant Healthcare (PHLT) United States $0.183B 0.00
Sera Prognostics (SERA) United States $0.144B 0.00
Biodesix (BDSX) United States $0.134B 0.00
So-Young (SY) China $0.114B 19.40
IceCure Medical (ICCM) Israel $0.083B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
ModivCare (MODV) United States $0.079B 4.29
Oncology Institute (TOI) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.061B 1.62
Singular Genomics Systems (OMIC) United States $0.051B 0.00
OncoCyte (OCX) United States $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
KindlyMD (KDLY) United States $0.018B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00